A serious complication of high-power short-duration radiofrequency atrial fibrillation ablation associated with genetic hypodysfibrinogenemia

HeartRhythm Case Rep. 2023 Aug 22;9(11):800-801. doi: 10.1016/j.hrcr.2023.08.008. eCollection 2023 Nov.

¹ The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
² Internal Medicine Residency Program, Providence Hospital/Michigan State University College of Human Medicine, Southfield, Michigan.
³ Division of Cardiovascular Diseases, Providence Hospital/Michigan State University College of Human Medicine, Southfield, Michigan.
⁴ Division of Hematology and Oncology, Providence Hospital/Michigan State University College of Human Medicine, Southfield, Michigan.

No abstract available

Keywords: Atrial fibrillation; Hypodysfibrinogenemia; Kagoshima mutation; Radiofrequency ablation; Tamponade.

Publication types